Daniel L Kastner Selected Research

COVID-19

1/2021

The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel L Kastner Research Topics

Disease

34	Inflammation (Inflammations) 01/2023 - 01/2003
22	Familial Mediterranean Fever (Periodic Disease) 12/2022 - 01/2003
15	Fever (Fevers) 10/2022 - 09/2003
13	Cryopyrin-Associated Periodic Syndromes 01/2022 - 12/2002
12	Rheumatoid Arthritis 02/2011 - 08/2004
8	VEXAS syndrome 02/2024 - 12/2020
8	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2022 - 01/2003
7	autosomal dominant familial Periodic fever 03/2012 - 08/2002
5	Mevalonate Kinase Deficiency 01/2022 - 09/2003
5	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 08/2004
5	Infections 01/2019 - 06/2009
5	Exanthema (Rash) 12/2014 - 09/2003
4	Urticaria (Hives) 02/2016 - 10/2012
3	Stroke (Strokes) 01/2023 - 12/2014
3	Skin Diseases (Skin Disease) 10/2022 - 11/2015
3	Arthritis (Polyarthritis) 10/2022 - 05/2008
3	Enterocolitis 01/2022 - 10/2012
3	Necrosis 01/2022 - 01/2018
3	deficiency of adenosine deaminase 2 01/2022 - 01/2019
3	Arthralgia (Joint Pain) 10/2012 - 09/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 10/2021
2	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2021
2	Systemic Vasculitis 01/2023 - 01/2019
2	Anemia 01/2023 - 12/2022
2	Splenomegaly 01/2023 - 12/2022
2	Chronic Disease (Chronic Diseases) 12/2022 - 11/2015
2	Headache (Headaches) 10/2022 - 04/2021
2	Macrophage Activation Syndrome 01/2022 - 01/2016
2	Bites and Stings (Sting) 01/2021 - 01/2016
2	Lipodystrophy 01/2021 - 11/2015
2	Chronic Inducible Urticaria 11/2020 - 02/2016
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018 - 12/2015
2	Disease Susceptibility (Diathesis) 01/2018 - 11/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 09/2008
2	Rheumatic Diseases (Rheumatism) 07/2015 - 07/2012
2	Common Variable Immunodeficiency 12/2014 - 01/2012
2	Bronchiolitis 12/2014 - 10/2012
2	Schmid-Fraccaro syndrome 12/2014 - 03/2014
2	Behcet Syndrome (Behcet's Syndrome) 06/2014 - 05/2013
2	Injection Site Reaction 10/2012 - 03/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2011 - 08/2004
2	Amyloidosis 06/2006 - 09/2002
1	Dermatitis 04/2024
1	Headache Disorders (Headache Syndromes) 01/2023
1	Macular Edema 01/2023
1	Retinal Dystrophies 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	Edema (Dropsy) 01/2023
1	Band-Shaped Corneal Dystrophy 01/2023
1	Ischemic Stroke 01/2023
1	Hypohidrosis 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
16	PyrinIBA 10/2022 - 12/2002
15	InflammasomesIBA 10/2022 - 09/2005
11	AutoantibodiesIBA 01/2020 - 12/2005
9	CytokinesIBA 01/2022 - 12/2002
7	EnzymesIBA 02/2024 - 09/2003
7	Interleukin-1 (Interleukin 1)IBA 01/2022 - 12/2002
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 09/2002
6	Adenosine DeaminaseIBA 01/2023 - 03/2014
6	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2011 - 08/2002
5	InterferonsIBA 01/2023 - 02/2011
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 12/2002
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017 - 06/2006
4	NF-kappa B (NF-kB)IBA 07/2009 - 11/2003
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2021 - 06/2006
3	mevalonate kinaseIBA 01/2016 - 09/2003
3	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 12/2002
3	AntigensIBA 06/2014 - 01/2009
3	Type I Tumor Necrosis Factor ReceptorsIBA 03/2011 - 08/2006
3	EpitopesIBA 12/2009 - 12/2005
3	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008 - 09/2005
3	Anti-Citrullinated Protein AntibodiesIBA 05/2008 - 12/2005
2	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2023 - 01/2022
2	SteroidsIBA 10/2022 - 04/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 03/2011
2	veltuzumabIBA 01/2021 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2018
2	Protein Isoforms (Isoforms)IBA 12/2020 - 11/2004
2	InterleukinsIBA 12/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 07/2017 - 07/2009
2	Cysteine (L-Cysteine)FDA Link 02/2016 - 09/2002
2	Mevalonic Acid (Mevalonate)IBA 01/2016 - 01/2005
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015 - 12/2005
2	Phospholipases (Phospholipase)IBA 12/2014 - 10/2012
2	Interleukin-10 (Interleukin 10)IBA 05/2013 - 02/2013
2	rilonacept FDA Link 10/2012 - 08/2008
2	Etanercept (Enbrel)FDA Link 03/2012 - 09/2003
2	LipopolysaccharidesIBA 03/2011 - 11/2004
2	human PSTPIP1 proteinIBA 11/2010 - 11/2003
2	cyclic citrullinated peptideIBA 12/2009 - 12/2005
2	Rheumatoid FactorIBA 12/2009 - 12/2005
2	TNF Receptor-Associated Factor 1IBA 07/2009 - 09/2007
2	Protein Tyrosine PhosphatasesIBA 10/2005 - 08/2004
1	sharpinIBA 04/2024
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	UbiquitinIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023

Therapy/Procedure

10	Therapeutics 01/2023 - 09/2002